Orgenesis (ORGS) Short Interest Ratio & Short Volume

$0.61

+0.00 (+0.73%)

(As of 09/13/2024 08:54 PM ET)

Orgenesis Short Interest Data

Orgenesis (ORGS) has a short interest of 405,100 shares. This marks a -9.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 179,002 shares to cover all short positions.

Current Short Interest: 405,100 shares
Previous Short Interest: 445,500 shares
Change Vs. Previous Month: -9.07%
Dollar Volume Sold Short: $271,376.49
Short Interest Ratio: 2.0 Days to Cover
Last Record Date: August 31, 2024

Outstanding Shares: 34,447,000 shares
Percentage of Shares Shorted: 1.18%
Today's Trading Volume: 67,400 shares
Average Trading Volume: 179,002 shares
Today's Volume Vs. Average: 38%

Short Selling Orgenesis?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

ORGS Short Interest Over Time

ORGS Days to Cover Over Time

ORGS Percentage of Float Shorted Over Time

Ad Capital Trends

More Than 30 Federal Agencies Buy From This Cybersecurity Tech

In January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukraine was used to cyberattacks. But the WhisperGate attack just before Russia's full-scale invasion was different. It was larger... and it was aimed at dismantling Ukraine's critical infrastructure. The company's unique expertise and scalable approach allowed them to nearly double revenues between 2021-2023, and they've added another $20 million in new sales orders this year alone. There is no denying - the opportunity here is massive.

Click here to learn how a small company is joining the ranks of Lockheed Martin and Raytheon

Orgenesis Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/31/2024	405,100 shares	$271,376.49	-9.1%	N/A	2	$0.67
8/15/2024	445,500 shares	$414,315.00	+23.8%	N/A	2.3	$0.93
7/31/2024	359,900 shares	$284,321.00	+48.4%	N/A	2.5	$0.79
7/15/2024	242,600 shares	$169,820.00	-10.9%	N/A	2.7	$0.70
6/30/2024	272,400 shares	$163,440.00	+39.8%	N/A	1.5	$0.60
6/15/2024	194,900 shares	$113,003.02	-5.1%	N/A	1	$0.58
Get the Latest News and Ratings for ORGS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter.
5/31/2024	205,400 shares	$105,760.46	-17.6%	N/A	1.3	$0.51
5/15/2024	249,300 shares	$141,029.01	-13.5%	N/A	1.4	$0.57
4/30/2024	288,100 shares	$145,605.74	-28.4%	N/A	1.3	$0.51
4/15/2024	402,500 shares	$201,129.25	+34.3%	N/A	1.7	$0.50
3/31/2024	299,700 shares	$246,353.40	-7.0%	N/A	1.9	$0.82
3/15/2024	322,200 shares	$254,280.24	+42.8%	N/A	2.2	$0.79
2/29/2024	225,700 shares	$144,493.14	-7.4%	N/A	1.5	$0.64
2/15/2024	243,800 shares	$117,024.00	+61.6%	N/A	1.7	$0.48
1/31/2024	150,900 shares	$47,382.60	+25.2%	N/A	1.6	$0.31
1/15/2024	120,500 shares	$36,029.50	-36.4%	N/A	1.3	$0.30
12/31/2023	189,500 shares	$94,882.65	+47.0%	N/A	2.4	$0.50
12/15/2023	128,900 shares	$63,844.17	-39.3%	N/A	1.8	$0.50
11/30/2023	212,300 shares	$97,997.68	-12.2%	N/A	3.4	$0.46
11/15/2023	241,900 shares	$133,045.00	+21.5%	N/A	2.4	$0.55
10/31/2023	199,100 shares	$135,407.91	-18.7%	0.8%	1.8	$0.68
10/15/2023	244,800 shares	$206,537.76	+18.4%	1.0%	2.5	$0.84
9/30/2023	206,800 shares	$128,216.00	-29.0%	0.9%	2.1	$0.62
9/15/2023	291,400 shares	$201,066.00	+45.4%	1.2%	3.1	$0.69
8/31/2023	200,400 shares	$102,023.64	+2.4%	0.9%	2.3	$0.51
8/15/2023	195,700 shares	$192,568.80	+8.6%	N/A	4.4	$0.98
7/31/2023	180,200 shares	$196,418.00	-13.3%	N/A	6.5	$1.09
7/15/2023	207,900 shares	$270,270.00	-7.2%	N/A	7.1	$1.30
6/30/2023	224,100 shares	$311,499.00	+13.6%	N/A	7.4	$1.39
6/15/2023	197,200 shares	$256,360.00	-1.0%	N/A	5.5	$1.30
5/31/2023	199,100 shares	$236,929.00	+6.9%	N/A	4.4	$1.19
5/15/2023	186,300 shares	$199,359.63	-11.5%	N/A	2.4	$1.07
4/30/2023	210,600 shares	$231,660.00	-43.4%	N/A	2.8	$1.10
4/15/2023	372,100 shares	$427,915.00	-17.2%	N/A	5	$1.15
3/31/2023	449,600 shares	$530,528.00	+47.5%	N/A	5.9	$1.18
3/15/2023	304,800 shares	$377,952.00	-19.1%	1.3%	4.3	$1.24
2/28/2023	376,800 shares	$542,592.00	+91.0%	1.6%	6.3	$1.44
2/15/2023	197,300 shares	$420,249.00	+0.4%	1.0%	3.4	$2.13
1/31/2023	196,600 shares	$471,840.00	-12.7%	1.0%	1.8	$2.40
1/15/2023	225,100 shares	$535,738.00	+2.4%	1.1%	2	$2.38
Trader Books $13M Profit on “Nvidia of Crypto” (Ad) A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips. Click here to review my research and the strategy I've developed for the opportunity to trade this c
12/30/2022	219,800 shares	$428,610.00	+4.9%	1.0%	2	$1.95
12/15/2022	209,500 shares	$427,380.00	-5.1%	1.0%	1.9	$2.04
11/30/2022	220,800 shares	$441,600.00	-25.9%	1.0%	2.1	$2.00
11/15/2022	298,000 shares	$643,680.00	+53.8%	1.4%	2.9	$2.16
10/31/2022	193,800 shares	$259,692.00	+2.1%	0.9%	1.8	$1.34
10/15/2022	189,900 shares	$241,173.00	-4.7%	0.8%	5.1	$1.27
9/30/2022	199,300 shares	$283,006.00	+28.5%	0.9%	5.8	$1.42
9/15/2022	155,100 shares	$285,384.00	-9.9%	0.7%	4.8	$1.84
8/31/2022	172,200 shares	$334,068.00	+13.1%	0.8%	5.1	$1.94
8/15/2022	152,300 shares	$284,801.00	-10.4%	0.7%	4.2	$1.87
7/31/2022	169,900 shares	$316,014.00	-17.0%	0.8%	4	$1.86
7/15/2022	204,600 shares	$460,350.00	-8.7%	0.9%	5.6	$2.25
6/30/2022	224,100 shares	$542,322.00	+37.7%	1.0%	6.2	$2.42
6/15/2022	162,700 shares	$323,773.00	-24.5%	0.7%	3.4	$1.99
5/31/2022	215,400 shares	$553,578.00	+52.4%	1.0%	4.8	$2.57
5/15/2022	141,300 shares	$402,705.00	-3.2%	0.6%	3.2	$2.85
4/30/2022	145,900 shares	$437,700.00	-27.6%	0.7%	4.8	$3.00
4/15/2022	201,500 shares	$687,115.00	+6.1%	0.9%	5.4	$3.41
3/31/2022	190,000 shares	$659,300.00	+2.9%	0.9%	4	$3.47
3/15/2022	184,700 shares	$528,242.00	-19.3%	0.9%	3.6	$2.86
2/28/2022	229,000 shares	$721,350.00	-11.9%	1.1%	3.7	$3.15
2/15/2022	259,900 shares	$813,487.00	+4.9%	1.3%	3.7	$3.13
1/31/2022	247,700 shares	$775,301.00	+12.8%	1.2%	3	$3.13
1/15/2022	219,600 shares	$507,276.00	-6.7%	1.0%	2.5	$2.31
12/31/2021	235,400 shares	$677,952.00	+0.3%	1.1%	2.8	$2.88
12/15/2021	234,600 shares	$694,416.00	+9.4%	1.1%	3.4	$2.96
11/30/2021	214,500 shares	$664,950.00	-14.8%	1.0%	3.4	$3.10
11/15/2021	251,700 shares	$1.02 million	-1.1%	1.2%	4.4	$4.06
10/29/2021	254,400 shares	$1.22 million	-17.3%	1.2%	4.7	$4.81
10/15/2021	307,500 shares	$1.46 million	-25.7%	1.4%	6.3	$4.76
9/30/2021	413,600 shares	$2.05 million	-27.9%	1.9%	8	$4.95
9/15/2021	573,800 shares	$2.85 million	-3.7%	2.7%	5.9	$4.96
8/31/2021	595,900 shares	$3.19 million	+3.0%	2.8%	5.1	$5.35
8/13/2021	578,500 shares	$2.99 million	-20.5%	2.7%	4.2	$5.16
7/30/2021	727,700 shares	$3.57 million	+8.9%	3.4%	4	$4.90
7/15/2021	668,300 shares	$3.21 million	-2.2%	3.1%	1.4	$4.80
6/30/2021	683,000 shares	$3.46 million	-62.7%	3.2%	1.5	$5.07
6/15/2021	1,830,000 shares	$9.50 million	No Change	8.5%	4.1	$5.19
5/28/2021	1,830,000 shares	$8.84 million	+16.6%	8.5%	4.1	$4.83
5/14/2021	1,570,000 shares	$6.92 million	+36.5%	N/A	3.5	$4.41
4/30/2021	1,150,000 shares	$5.42 million	+31.0%	N/A	2.6	$4.71
4/15/2021	878,000 shares	$4.64 million	+16.6%	N/A	6	$5.28
3/31/2021	753,000 shares	$4.18 million	+37.8%	N/A	4.1	$5.55
3/15/2021	546,600 shares	$4.42 million	+62.6%	N/A	3.1	$8.08
2/26/2021	336,100 shares	$2.32 million	+6.9%	N/A	2.2	$6.89
2/12/2021	314,500 shares	$2.09 million	-3.5%	N/A	2.4	$6.66
1/29/2021	326,000 shares	$2.04 million	-2.1%	N/A	2.9	$6.25
1/15/2021	332,900 shares	$1.70 million	-2.7%	N/A	3.3	$5.12
12/31/2020	342,200 shares	$1.56 million	+2.9%	N/A	6.6	$4.55
12/15/2020	332,600 shares	$1.57 million	-13.4%	N/A	7.2	$4.72
Trader Books $13M Profit on “Nvidia of Crypto” (Ad) A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips. Click here to review my research and the strategy I've developed for the opportunity to trade this c
11/30/2020	384,100 shares	$1.90 million	+0.6%	N/A	8.8	$4.95
11/15/2020	382,000 shares	$1.86 million	-0.2%	N/A	8.9	$4.86
10/30/2020	382,700 shares	$1.78 million	-8.9%	N/A	8.9	$4.66
10/15/2020	420,200 shares	$2.21 million	-0.9%	N/A	8.8	$5.26

ORGS Short Interest - Frequently Asked Questions

What is Orgenesis' current short interest?: Short interest is the volume of Orgenesis shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 405,100 shares of ORGS short. Learn More on Orgenesis' current short interest.
What is a good short interest ratio for Orgenesis?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGS shares currently have a short interest ratio of 2.0. Learn More on Orgenesis's short interest ratio.
Is Orgenesis' short interest increasing or decreasing?: Orgenesis saw a decrease in short interest in August. As of August 31st, there was short interest totaling 405,100 shares, a decrease of 9.1% from the previous total of 445,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does Orgenesis' short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Orgenesis: Enlivex Therapeutics Ltd. (0.45%), AlloVir, Inc. (4.97%), Genelux Co. (4.16%), Vistagen Therapeutics, Inc. (3.26%), InflaRx (0.37%), Relmada Therapeutics, Inc. (4.01%), Tiziana Life Sciences Ltd (0.12%), Clearside Biomedical, Inc. (0.45%), Cidara Therapeutics, Inc. (1.24%), Aclaris Therapeutics, Inc. (2.41%),

Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.
What does it mean to sell short Orgenesis stock?: Short selling ORGS is an investing strategy that aims to generate trading profit from Orgenesis as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Orgenesis?: A short squeeze for Orgenesis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGS, which in turn drives the price of the stock up even further.
How often is Orgenesis' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGS, twice per month. The most recent reporting period available is August, 31 2024.